Lisuride in parkinsonism

we studied the actions of lisuride, a dopaminergic ergot derivative, in 20 parkinsonian patients. When the dose was increased gradually, most patients tolerated up to 5 mg daily. Clinical assessment and objective, computer-assisted evaluation revealed improvement in akinesia, rigidity and tremor. Adverse reactions were similar to those seen with levodopa and bromocriptine, but somnolence tended to occur more often with lisuride.

[1]  R. Wurtman,et al.  Serotonergic neurones are not involved in action of L-dopa in Parkinson's disease , 1980, Nature.

[2]  M. Trabucchi,et al.  Dopamine receptors and sleep induction in man. , 1979, Journal of neurology, neurosurgery, and psychiatry.

[3]  J. Kebabian,et al.  Multiple receptors for dopamine , 1979, Nature.

[4]  W. Burkard,et al.  Effects of lisuride and LSD on cerebral monoamine systems and hallucinosis , 1978, Nature.

[5]  D. Calne,et al.  BROMOCRIPTINE AND LEVODOPA (WITH OR WITHOUT CARBIDOPA) IN PARKINSONISM , 1976, The Lancet.

[6]  R. Horowski,et al.  Direct dopaminergic action of lisuride hydrogen maleate, an ergot derivative, in mice. , 1976, European journal of pharmacology.

[7]  R. Horowski,et al.  Effect of the ergot derivative lisuride hydrogen maleate on serum prolactin concentrations in female rats. , 1976, Endocrinology.

[8]  K. Fuxe,et al.  Effect of ergot drugs on central 5-hydroxytryptamine neurons: evidence for 5-hydroxytryptamine release or 5-hydroxytryptamine receptor stimulation. , 1975, European journal of pharmacology.

[9]  A. Dlabač,et al.  Lysenyl, a New Antiserotonin Agent , 1972 .

[10]  S Fahn,et al.  Monoamines in the human neostriatum: topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor. , 1971, Journal of the neurological sciences.

[11]  N Sitaram,et al.  The neuropharmacology of sleep and wakefulness. , 1978, Annual review of pharmacology and toxicology.

[12]  J. Vardi,et al.  EEG sleep study in parkinsonian patients under bromocryptine treatment. , 1978, European Neurology.